MetLife, Inc. cash flow to debt ratio of 89.70% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

MetLife, Inc.'s free cash flow has increased 19.77% from $15.12G last year to $18.11G, signaling increasing performance

MetLife, Inc.'s debt to equity ratio is 0.74, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

MetLife, Inc.'s debt has increased relative to shareholder equity from 0.68 last year to 0.74 today, signaling weakened financials

MetLife, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

MetLife, Inc.'s interest coverage ratio of 4.51 indicates that earnings with good margin can cover interest payments on company debt

MetLife, Inc.'s profit margin has decreased (-25.68%) in the last year from 6.33% to 4.70%, signaling decreasing performance

MetLife, Inc.'s short-term liabilities of $276.14G exceed its short-term assets of $179.59G, signaling financial risk

MetLife, Inc.'s return on assets of 0.49% is lower than the 5.00% threshold, indicating inefficient asset utilization

MetLife, Inc.'s return on equity of 12.88%, is lower than 15.00%, indicating bad performance

MetLife, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

MetLife, Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings

MetLife, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

MetLife, Inc. has a free cash flow yield of 32.74%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

MetLife, Inc.'s yearly earnings has decreased -23.66% since last year from $4.43G to $3.38G, signaling decreasing performance

MetLife, Inc.'s yearly revenue has increased 8.60% since last year from $70.98G to $77.08G, signaling increasing performance

ROIC 0.49% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

MetLife, Inc.'s 3-year revenue CAGR of 4.29% is positive, indicating growing revenue over the past 3 years

MetLife, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

MetLife, Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity

MetLife, Inc. is undervalued relative to its fair value price of 480.53 based on Discounted Cash Flow model

MetLife, Inc. has an earnings yield of 6.46%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

MetLife, Inc. is overvalued relative to its fair value price of 63.60 based on EBITDA multiple model

MetLife, Inc. has an EV/EBITDA ratio of 8.99x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

MetLife, Inc. is undervalued relative to its fair value price of 100.52 based on Earnings Fair Value model

MetLife, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

MetLife, Inc. has a price-to-book ratio of 2.05x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

MetLife, Inc. has a price-to-sales ratio of 0.72x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue